Home
About Us
Our Team
The Urihk Partnership
Products
Antibiotic
Antifungal
Anticoagulant
Immuno modulator
Neuro/CNS
Services
Learn More
News
Gallery
Careers
Contact Us
Select Page
Back
Oct 25, 2021
Colistin: Re-emergence of the ‘forgotten’ antimicrobial agent
Oct 25, 2021
Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients
Oct 25, 2021
Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa
Oct 25, 2021
Use of colistin in the treatment of multiple-drug-resistant gram-negative infections
